1. Method of detection (A, B) 2. A computer algorithm to enable CV risk assessment over one to 5 years (A) 3. Detection of heart failure using thorombospondin 2 (B) 4. Pharmaceuticals containing thrombospondin 2 for heart failure treatment (B). The gene discussed is THBS2; the disease is heart failure.